Vimian Group AB (publ) (VIMGF)
OTCMKTS · Delayed Price · Currency is USD
3.010
-1.290 (-30.00%)
At close: Sep 10, 2025
Vimian Group AB Market Cap
Vimian Group AB has a market cap or net worth of $1.58 billion as of October 14, 2025. Its market cap has decreased by -30.88% in one year.
Market Cap
1.58B
Enterprise Value
1.85B
Revenue
474.81M
Ranking
n/a
PE Ratio
58.84
Stock Price
$3.01
Market Cap Chart
Since June 18, 2021, Vimian Group AB's market cap has decreased from 3.65B to 1.58B, a decrease of -56.78%. That is a compound annual growth rate of -17.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 1.57B | -16.50% |
| Dec 30, 2024 | 1.89B | 40.53% |
| Dec 29, 2023 | 1.34B | 23.45% |
| Dec 30, 2022 | 1.09B | -68.17% |
| Dec 30, 2021 | 3.41B | -6.35% |
| Jun 18, 2021 | 3.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 673.15M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 334.34M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |